AR226864A1 - Procedimiento para la preparacion de 4-(2-hidroxietiltiometil)-piridina antiinflamatoria e inmunorreguladora - Google Patents

Procedimiento para la preparacion de 4-(2-hidroxietiltiometil)-piridina antiinflamatoria e inmunorreguladora

Info

Publication number
AR226864A1
AR226864A1 AR282823A AR28282380A AR226864A1 AR 226864 A1 AR226864 A1 AR 226864A1 AR 282823 A AR282823 A AR 282823A AR 28282380 A AR28282380 A AR 28282380A AR 226864 A1 AR226864 A1 AR 226864A1
Authority
AR
Argentina
Prior art keywords
hydroxyethyltiomethyl
inflammatory
pyridine
procedure
preparation
Prior art date
Application number
AR282823A
Other languages
English (en)
Spanish (es)
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Application granted granted Critical
Publication of AR226864A1 publication Critical patent/AR226864A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/28—Radicals substituted by singly-bound oxygen or sulphur atoms
    • C07D213/32—Sulfur atoms
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01D—HARVESTING; MOWING
    • A01D34/00—Mowers; Mowing apparatus of harvesters
    • A01D34/001—Accessories not otherwise provided for
    • A01D34/003—Means for cleaning the machine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29C—SHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING
    • B29C33/00—Moulds or cores; Details thereof or accessories therefor
    • B29C33/56—Coatings, e.g. enameled or galvanised; Releasing, lubricating or separating agents
    • B29C33/60—Releasing, lubricating or separating agents
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29C—SHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING
    • B29C70/00—Shaping composites, i.e. plastics material comprising reinforcements, fillers or preformed parts, e.g. inserts
    • B29C70/68—Shaping composites, i.e. plastics material comprising reinforcements, fillers or preformed parts, e.g. inserts by incorporating or moulding on preformed parts, e.g. inserts or layers, e.g. foam blocks
    • B29C70/84—Shaping composites, i.e. plastics material comprising reinforcements, fillers or preformed parts, e.g. inserts by incorporating or moulding on preformed parts, e.g. inserts or layers, e.g. foam blocks by moulding material on preformed parts to be joined
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/55—Acids; Esters
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62—Oxygen or sulfur atoms
    • C07D213/63—One oxygen atom
    • C07D213/65—One oxygen atom attached in position 3 or 5
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/26—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
    • F16—ENGINEERING ELEMENTS AND UNITS; GENERAL MEASURES FOR PRODUCING AND MAINTAINING EFFECTIVE FUNCTIONING OF MACHINES OR INSTALLATIONS; THERMAL INSULATION IN GENERAL
    • F16C—SHAFTS; FLEXIBLE SHAFTS; ELEMENTS OR CRANKSHAFT MECHANISMS; ROTARY BODIES OTHER THAN GEARING ELEMENTS; BEARINGS
    • F16C11/00—Pivots; Pivotal connections
    • F16C11/04—Pivotal connections
    • F16C11/06—Ball-joints; Other joints having more than one degree of angular freedom, i.e. universal joints
    • F16C11/0604—Construction of the male part
    • F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
    • F16—ENGINEERING ELEMENTS AND UNITS; GENERAL MEASURES FOR PRODUCING AND MAINTAINING EFFECTIVE FUNCTIONING OF MACHINES OR INSTALLATIONS; THERMAL INSULATION IN GENERAL
    • F16C—SHAFTS; FLEXIBLE SHAFTS; ELEMENTS OR CRANKSHAFT MECHANISMS; ROTARY BODIES OTHER THAN GEARING ELEMENTS; BEARINGS
    • F16C11/00—Pivots; Pivotal connections
    • F16C11/04—Pivotal connections
    • F16C11/06—Ball-joints; Other joints having more than one degree of angular freedom, i.e. universal joints
    • F16C11/068—Special features relating to lubrication

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Mechanical Engineering (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Environmental Sciences (AREA)
  • Composite Materials (AREA)
  • Transplantation (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
AR282823A 1979-10-15 1980-10-09 Procedimiento para la preparacion de 4-(2-hidroxietiltiometil)-piridina antiinflamatoria e inmunorreguladora AR226864A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/085,011 US4246263A (en) 1979-10-15 1979-10-15 Antiinflammatory and immunoregulatory pyrimidines, their method of use and pharmaceutical compositions

Publications (1)

Publication Number Publication Date
AR226864A1 true AR226864A1 (es) 1982-08-31

Family

ID=22188737

Family Applications (3)

Application Number Title Priority Date Filing Date
AR282823A AR226864A1 (es) 1979-10-15 1980-10-09 Procedimiento para la preparacion de 4-(2-hidroxietiltiometil)-piridina antiinflamatoria e inmunorreguladora
AR288464A AR227576A1 (es) 1979-10-15 1982-02-18 Procedimiento para la preparacion de nuevas piridinas antiinflamatorias e inmunorreguladoras
AR288463A AR227089A1 (es) 1979-10-15 1982-02-18 Procedimiento para la preparacion de nuevas piridinas y pirimidinas antiinflamatorias e inmunorreguladoras

Family Applications After (2)

Application Number Title Priority Date Filing Date
AR288464A AR227576A1 (es) 1979-10-15 1982-02-18 Procedimiento para la preparacion de nuevas piridinas antiinflamatorias e inmunorreguladoras
AR288463A AR227089A1 (es) 1979-10-15 1982-02-18 Procedimiento para la preparacion de nuevas piridinas y pirimidinas antiinflamatorias e inmunorreguladoras

Country Status (39)

Country Link
US (1) US4246263A (de)
JP (1) JPS5663962A (de)
KR (2) KR840001614B1 (de)
AR (3) AR226864A1 (de)
AT (2) AT377513B (de)
AU (1) AU517763B2 (de)
BE (1) BE885709A (de)
CA (1) CA1156231A (de)
CH (1) CH646425A5 (de)
CS (2) CS226020B2 (de)
DD (2) DD154816B3 (de)
DE (1) DE3038593A1 (de)
DK (1) DK152427C (de)
EG (1) EG14676A (de)
ES (2) ES8201972A1 (de)
FI (1) FI75560C (de)
FR (1) FR2467199A1 (de)
GB (2) GB2061928B (de)
GR (1) GR70311B (de)
HK (2) HK1185A (de)
HU (2) HU183233B (de)
IE (1) IE50665B1 (de)
IL (1) IL61261A (de)
IN (2) IN154554B (de)
IT (1) IT1195269B (de)
KE (2) KE3461A (de)
LU (1) LU82844A1 (de)
MY (2) MY8500323A (de)
NL (1) NL8005652A (de)
NO (1) NO156566C (de)
NZ (1) NZ195246A (de)
PH (1) PH18277A (de)
PL (2) PL125402B1 (de)
PT (1) PT71917B (de)
SE (1) SE437023B (de)
SG (2) SG56384G (de)
SU (2) SU1083907A3 (de)
YU (2) YU41740B (de)
ZA (1) ZA806306B (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4371696A (en) * 1980-07-14 1983-02-01 Pfizer Inc. Certain pyridine methylthio acetaldehyde derivatives and non-cyclic and cyclic acetals thereof
GB8405896D0 (en) * 1984-03-07 1984-04-11 Sandoz Ltd Organic compounds
EP0311616B1 (de) * 1986-06-17 1991-09-25 Biogen, Inc. Kombination von gammainterferonen und antientzündungsmitteln oder antipyretischen mitteln zur behandlung von krankheiten
US6878743B2 (en) * 2001-09-18 2005-04-12 Sunesis Pharmaceuticals, Inc. Small molecule inhibitors of caspases
PL1896401T3 (pl) * 2005-02-25 2014-03-31 Univ Temple Synteza nienasyconych siarczków, sulfonów, sulfotlenków i sulfonamidów
TW200917961A (en) * 2007-08-23 2009-05-01 Sumitomo Chemical Co Fluorine-containing organosulfur compound and pesticidal composition thereof
CN108530606B (zh) * 2018-04-19 2020-11-20 山东师范大学 一种pH敏感性医用聚氨酯脲材料及其制备方法
US11981625B2 (en) 2018-10-08 2024-05-14 Ecolab Usa Inc. Sulfide-based compounds and uses thereof
CN110483740B (zh) * 2019-08-12 2021-08-27 山东师范大学 一种聚合物、pH敏感性纳米囊泡及制备方法与应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3409626A (en) * 1963-09-17 1968-11-05 Neisler Lab Inc Indolylethyl pyridinium quaternary ammonium compounds
NL144484B (nl) * 1967-07-26 1975-01-15 Merck & Co Inc Werkwijze ter bereiding van een geneesmiddel met anti-anflammatoire werking, alsmede werkwijze ter bereiding van de anti-inflammatoir werkzame aralkylmercaptoaminozuren.
US3558640A (en) * 1967-12-20 1971-01-26 Merck & Co Inc Certain pyridyl and thiazolyl methylthiopropionic acids and derivatives
US3636074A (en) * 1968-08-05 1972-01-18 Hooker Chemical Corp Novel mercaptophenol derivatives
US3591584A (en) 1968-08-27 1971-07-06 Pfizer Benzothiazine dioxides
US3818009A (en) * 1969-12-29 1974-06-18 Lilly Co Eli Alpha, alpha-disubstituted-5-pyrimidinemethanes
US3676463A (en) 1970-10-15 1972-07-11 Pfizer Oxobenzofuran carboxamides
US3707475A (en) 1970-11-16 1972-12-26 Pfizer Antiinflammatory imidazoles
JPS52125170A (en) * 1976-04-12 1977-10-20 Yoshitomi Pharmaceut Ind Ltd Pyridine derivatives

Also Published As

Publication number Publication date
NO156566C (no) 1987-10-14
YU42059B (en) 1988-04-30
SE8007193L (sv) 1981-04-16
DE3038593C2 (de) 1988-11-10
GB2061928A (en) 1981-05-20
AT377513B (de) 1985-03-25
DD202543A5 (de) 1983-09-21
AR227576A1 (es) 1982-11-15
NO803073L (no) 1981-04-21
AU6324080A (en) 1981-04-30
NL8005652A (nl) 1981-04-21
ATA508980A (de) 1984-08-15
FI75560B (fi) 1988-03-31
CA1156231A (en) 1983-11-01
DD154816B3 (de) 1987-05-13
ES495932A0 (es) 1982-01-16
GB2061928B (en) 1983-06-02
FR2467199A1 (fr) 1981-04-17
YU262680A (en) 1983-09-30
IL61261A (en) 1984-08-31
JPS5663962A (en) 1981-05-30
EG14676A (en) 1985-03-31
AU517763B2 (en) 1981-08-27
KE3466A (en) 1984-11-09
FR2467199B1 (de) 1984-12-28
IN154554B (de) 1984-11-10
GB2092133A (en) 1982-08-11
ES8206478A1 (es) 1982-08-16
SG69184G (en) 1985-03-15
FI75560C (fi) 1988-07-11
HU183233B (en) 1984-04-28
SE437023B (sv) 1985-02-04
HK1185A (en) 1985-01-11
DK403080A (da) 1981-04-16
ZA806306B (en) 1981-10-28
GB2092133B (en) 1983-03-16
PL227307A1 (de) 1981-11-13
PL231782A1 (de) 1982-03-01
YU41740B (en) 1987-12-31
IE50665B1 (en) 1986-06-11
FI803239L (fi) 1981-04-16
LU82844A1 (fr) 1981-06-04
IT8025324A0 (it) 1980-10-14
PL125402B1 (en) 1983-05-31
MY8500325A (en) 1985-12-31
PT71917A (en) 1980-12-01
AT379801B (de) 1986-03-10
CS226034B2 (en) 1984-03-19
IE802125L (en) 1981-04-15
KR830004263A (ko) 1983-07-09
BE885709A (fr) 1981-04-14
HK66887A (en) 1987-09-25
ES505544A0 (es) 1982-08-16
SG56384G (en) 1985-03-08
DD154816A5 (de) 1982-04-21
SU1083907A3 (ru) 1984-03-30
US4246263A (en) 1981-01-20
ATA268783A (de) 1985-07-15
DK152427B (da) 1988-02-29
PL125314B1 (en) 1983-04-30
IN163553B (de) 1988-10-08
MY8500323A (en) 1985-12-31
NZ195246A (en) 1983-07-15
NO156566B (no) 1987-07-06
DE3038593A1 (de) 1981-04-23
HU191824B (en) 1987-04-28
IT1195269B (it) 1988-10-12
AR227089A1 (es) 1982-09-15
PT71917B (en) 1983-01-10
JPS6129342B2 (de) 1986-07-05
CH646425A5 (fr) 1984-11-30
PH18277A (en) 1985-05-17
YU266882A (en) 1983-09-30
GR70311B (de) 1982-09-08
DK152427C (da) 1988-07-25
SU1144617A3 (ru) 1985-03-07
KR840001615B1 (ko) 1984-10-11
IL61261A0 (en) 1980-12-31
ES8201972A1 (es) 1982-01-16
KE3461A (en) 1984-10-12
KR840001614B1 (ko) 1984-10-11
CS226020B2 (en) 1984-03-19

Similar Documents

Publication Publication Date Title
ES494634A0 (es) Procedimiento para la preparacion de compuestos de cefem y cefam
ES498224A0 (es) Procedimiento para la preparacion de sulfonilureas
ES491913A0 (es) Procedimiento para la preparacion de betainas
MX5676E (es) Procedimiento mejorado para la preparacion de cicloalcanoles y cicloalcanonas
ES489628A0 (es) Procedimiento para la obtencion de derivados de tetrahidro- piridina y piperidina
AR227645A1 (es) Procedimiento para la preparacion de oxoalcohilxantinas
AR221355A1 (es) Procedimiento para la preparacion de derivados de pirrolidinil y pirrolidinilmetil-benzamidas
ES495179A0 (es) Procedimiento para la preparacion de polieterpoliaminas
ES493774A0 (es) Procedimiento para la preparacion de 3-amino-sidnoniminas
ES497100A0 (es) Procedimiento para la preparacion de sulfonilureas
AR226864A1 (es) Procedimiento para la preparacion de 4-(2-hidroxietiltiometil)-piridina antiinflamatoria e inmunorreguladora
ES493300A0 (es) Procedimiento para la preparacion de acilureas
ES487746A0 (es) Procedimiento para la preparacion de bis-estiril-benceno
ES490420A0 (es) Procedimiento para la preparacion de diestirilbifenilos
ES490421A0 (es) Procedimiento para la preparacion de diestirilbencenos
ES491527A0 (es) Procedimiento para la preparacion de tiazoliliden-oxo-pro- pionitrilos
ES494856A0 (es) Procedimiento para la preparacion de n-aril-n-acil-3-amino- oxazolidin-2-onas
AR225813A1 (es) Procedimiento para la preparacion de 3-picolina
AR225159A1 (es) Procedimiento para la preparacion de l-alpha-gliceril-fosforilcolina
ES490620A0 (es) Procedimiento para la preparacion de 3-alcoxi-6-alquiliden- hidracionopiridacina
MX6151E (es) Procedimiento para la preparacion de 7-acilindolinas
ES497659A0 (es) Procedimiento para la preparacion de sulfonilureas
ES493001A0 (es) Procedimiento para la preparacion de metilglioxal
AR227629A1 (es) Procedimiento para la preparacion esteroespecifica o esteroselectiva de derivados de imidazolil-oxi-meteres y derivados de imidazoliloximas
AR223383A1 (es) Procedimiento para la preparacion de 2-isopropilamino-pirimidina